We are live on
!
Find out more
ISL
Ingalls & Snyder LLC Portfolio holdings
AUM
$2.83B
1-Year Est. Return
21.61%
This Fund
S&P 500
This Quarter
Est. Return
+6.29%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$2.72B
AUM Growth
-$335M
(-11%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-4.39%
Top 10 Holdings %
Top 10 Hldgs %
37.43%
Holding
493
New
11
Increased
90
Reduced
235
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Q
Qnity Electronics Inc
Q
|
+$4.38M |
| 2 |
T-Mobile US
TMUS
|
+$3.04M |
| 3 |
Uber
UBER
|
+$2.88M |
| 4 |
FMC
FMC
|
+$2.17M |
| 5 |
Kenvue
KVUE
|
+$1.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$39.5M |
| 2 |
ExxonMobil
XOM
|
+$13M |
| 3 |
STMicroelectronics
STM
|
+$8.14M |
| 4 |
Canadian Natural Resources
CNQ
|
+$5.78M |
| 5 |
Omeros
OMER
|
+$5.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.25% |
| 2 | Technology | 15.23% |
| 3 | Financials | 13.14% |
| 4 | Energy | 12.25% |
| 5 | Industrials | 8.68% |
Similar funds
GS
SL
AF
SIC
ADEF
AIP
SAI
FISPB
Ingalls & Snyder LLC's Q4 2025 Portfolio in Review
As of Q4 2025, Ingalls & Snyder LLC held 493 positions worth $2.72B, down 11% from $3.06B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Ingalls & Snyder LLC withdrew a net $120M in Q4 2025, closing 26 positions and reducing 235 holdings. Its most notable exit was Brighthouse Financial, an estimated $1.38M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
Against the trend, Ingalls & Snyder LLC opened a new position in Qnity Electronics Inc worth $4.21M.
- Ingalls & Snyder LLC's largest Q4 2025 buy was Qnity Electronics Inc: 51,552 shares worth $4.21M.
- Ingalls & Snyder LLC added most to T-Mobile US in Q4 2025, an estimated $3.04M increase.
- Ingalls & Snyder LLC's biggest Q4 2025 reduction was Corcept Therapeutics, cutting an estimated $39.5M.
- Ingalls & Snyder LLC fully exited Brighthouse Financial in Q4 2025, selling an estimated $1.38M.
- Ingalls & Snyder LLC's ten largest holdings make up 37% of its $2.72B portfolio in Q4 2025.
- Ingalls & Snyder LLC opened 11 new positions and closed 26 in Q4 2025.
- Ingalls & Snyder LLC's portfolio value fell 11% quarter-over-quarter to $2.72B.
Based on Ingalls & Snyder LLC's 13F filing for Q4 2025, filed 13 Feb 2026.